13D/13G Filings - Repare Therapeutics Inc. (RPTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
4:27 pm
Purchase
2020-12-31 13G Repare Therapeutics Inc.
RPTX
Redmile Group LLC 2,647,696
7.200%
2,647,696increase
(New Position)
Filing
History
2021-02-12
4:22 pm
Purchase
2020-12-31 13G Repare Therapeutics Inc.
RPTX
BIOTECHNOLOGY VALUE FUND L P 2,972,191
8.100%
1,027,645increase
(+52.85%)
Filing
History
2021-02-08
10:31 am
Purchase
2021-02-05 13G Repare Therapeutics Inc.
RPTX
FMR LLC 2,757,375
7.499%
2,757,375increase
(New Position)
Filing
History
2021-01-25
4:27 pm
Sale
2021-01-14 13D Repare Therapeutics Inc.
RPTX
Versant Venture Capital V L.P. 3,144,451
8.600%
-275,000decrease
(-8.04%)
Filing
History
Goto Prev, 0, 1, 2